On November 11, the "High-Quality Development Forum on Nuclear Technology Applications," themed "Nuclear Technology for a Better Life," was successfully held in Zhuhai, Guangdong. Deputy Director of the State Administration of Science, Technology, and Industry for National Defense, Bian Zhigang, attended and delivered a speech. Wang Yiren, Deputy Director of the National Defense Science and Technology Commission, and Deng Jianjun, Academician of the Chinese Academy of Engineering, gave keynote reports. Novel Medical was invited to the event to showcase its innovative products with fully independent intellectual property rights to leaders, experts, international representatives, and industry peers.
This forum was organized by the News and Propaganda Center of the China Atomic Energy Authority and co-hosted by the National Nuclear Security Technology Center, Tongfang Co., Ltd., CGN Nuclear Technology Development Co., Ltd., State Nuclear Uranium Resource Development Company, LTD., and the China Isotope and Radiation Association. Approximately 150 participants attended, including representatives from various national ministries such as the Ministry of Industry and Information Technology, the Ministry of Transport, the Ministry of Ecology and Environment, the Ministry of Science and Technology, nuclear-related centers and R&D centers of the China Atomic Energy Authority, local defense industry offices, central enterprises, research institutions, industry associations, and private enterprises.
Novel Medical presented innovative products in the fields of nuclear medicine and nuclear security at the forum, attracting widespread attention from attending leaders and peers.
In the field of nuclear medicine, leveraging decades of world-class medical physics research from Tsinghua University, Novel Medical has achieved multiple technical breakthroughs in clinical and preclinical molecular imaging equipment, filling gaps in the domestic market.
In 2023, the National Innovative Medical Device, Insight 4D Quantitative SPECT/CT, was approved for market release, filling a domestic gap and reaching international advanced levels. It was recognized as a "Significant Medical Advancement of 2023" by the Chinese Academy of Medical Sciences.
The multimodal animal PET/SPECT/CT system, with its outstanding technical advantages, has become the most recognized domestic preclinical nuclear medicine research equipment. It is currently operating in numerous renowned medical institutions and research units in China, successfully collecting over 10,000 samples and participating in various radiopharmaceutical developments, providing important scientific evidence for the integration of nuclear medicine diagnosis and treatment.
In the field of nuclear security, Novel Medical's "Radiation Locating and Imaging System" is a leading international nuclear radiation monitoring device, solving major technical challenges of traditional equipment such as low inspection efficiency, inability to precisely locate and track radiation sources in real time. It enables real-time automatic positioning, tracking, and long-distance, all-round visual monitoring.
The product is widely used in emergency nuclear radiation monitoring for the military, police, firefighting, environmental protection, customs, major diplomatic events, and anti-nuclear terrorism inspections.
Language
